Bcl-2 is known to be a possible indicator for therapy response during induction chemotherapy treatment of adult patients with ALL[28], and Bcl-2 inhibition in combination with methadone increases the induction of apoptosis in pediatric ALL cells[29]. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.